Abstract
No AccessJournal of UrologyAdult urology1 May 2007Editorial Comment Leonard G. Gomella Leonard G. GomellaLeonard G. Gomella More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2007.01.199AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, 177(5), p. 1752 References 1 : Chemoprevention of prostate cancer in men at high risk: rationale and design of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial. J Urol2004; 172: 1314. Link, Google Scholar 2 : New imaging techniques in prostate cancer. Curr Urol Rep2006; 7: 175. Google Scholar Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania© 2007 by American Urological AssociationFiguresReferencesRelatedDetails Volume 177Issue 5May 2007Page: 1752 Advertisement Copyright & Permissions© 2007 by American Urological AssociationMetricsAuthor Information Leonard G. Gomella More articles by this author Expand All Advertisement PDF downloadLoading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
